Expression pattern of osteopontin and αvβ3 integrin during the implantation window in infertile patients with early stages of endometriosis.
BACKGROUND
To study endometrial receptivity in terms of osteopontin (OPN) and αvβ3 integrin expression and co-expression in infertile women with early stages of endometriosis.


METHODS
We investigated the immunohistochemical expression and co-expression of OPN and αvβ3 integrin in the endometrium of 20 infertile patients with Stage I or II endometriosis as the only detectable cause of infertility, 20 infertile patients with unexplained infertility and 20 fertile women undergoing tubal sterilization. Two endometrial biopsies were performed during a single menstrual cycle (postovulatory Day +7 to +8 and 4 days later) in each subject.


RESULTS
No statistically significant differences regarding OPN and αvβ3 integrin expression were found between infertile patients with endometriosis and the two control groups. There was no significant correlation between OPN and αvβ3 integrin staining intensity in the mid-luteal phase biopsies in any of the groups studied.


CONCLUSIONS
Endometrial OPN and αvβ3 integrin expression or co-expression is not impaired during the window of implantation in patients with Stage I-II endometriosis. Further studies are needed to determine whether these results imply normal endometrial receptivity in such patients or add to the increasing uncertainty about the clinical value of assessing the endometrium with these markers of implantation.
Institut Clinic of Gynaecology, Obstetrics and Neonatology, Hospital Clínic - Institut d'Investigacions Biomèdiques August Pi i Sunyer, c/Casanova 143, 08036 Barcelona, Spain.
Gemma
G
Casals
Jaume
J
Ordi
Montse
M
Creus
Francisco
F
Fábregues
Francisco
F
Carmona
Roser
R
Casamitjana
Juan
J
Balasch
D010064:Embryo Implantation; D004715:Endometriosis / Q000150:complications / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000150:complications / Q000378:metabolism*; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D053495:Osteopontin / Q000378:metabolism*
D039302:Integrin alphaVbeta3; D053495:Osteopontin